Laboratory

Discover our products

Clinical

Discovers our solutions

DeepChek®-HIV RT/PROT and DeepChek®-HIV INT Genotyping Assays Successfully Passed 2016 National Quality Control Program with 100% Accuracy.

Sep 19, 2017

We are pleased to announce that the DeepChek®-HIV RT/PROT assay and the DeepChek®-HIV INT assay successfully passed a national and independent quality control program in France and Switzerland and obtained 100% positive results on sensibility, 100% on specificity and also 100% on scoring on HIV geno…
Read more
Highlights on innovative molecular biology assays designed for detection, quantification and genotyping applications in virology

Sep 08, 2017

Together with our partner in Italy, Technogenetics, we are delighted to have two international experts in the field of molecular virology share their experience in clinical microbiology and laboratory management using our solutions (reagents and software) at the Technogenetics Satellite Symposium or…
Read more
ABL Announces Distribution Agreement with ABALAT in Mexico

Sep 04, 2017

Advanced Biological Laboratories (ABL) S.A. and ABALAT S.A. are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Mexico. See current channel partners.
Read more

Information Note – September 2017

Sep 01, 2017

We are pleased to share with you recent updates on ABL Diagnostics solutions: DeepChek Software v3.27 released including: Largescale mode: launch analyses on multiple samples simultaneously New One-page Report New version of HIVDB drug resistance guidelines (v8.4) HCV reference subtypes updated acco…
Read more
ABL Announces Distribution Agreement with SafeBlood BioAnalytica S.A. in Greece

Jul 27, 2017

Advanced Biological Laboratories (ABL) S.A. and SafeBlood BioAnalytica S.A. are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Greece. See current channel partners.
Read more
Immediate Availability of New DeepChek Assays for HIV-1 V3/Tropism Determination and Viral Hepatitis B Genotyping

Jul 10, 2017

ABL is pleased to announce the immediate available of two new DeepChek® Assays intended to be used for: Determining eligibility for CCR5 antagonist treatment in patients infected with human immunodeficiency virus 1 (HIV-1) – DeepChek®-HIV V3 Loop/Tropism Assay HBV genotyping, drug resistance a…
Read more

Advanced Biological Laboratories and Right to Care collaborate to strengthen HIV treatment

Jul 04, 2017

Advanced Biological Laboratories S.A. and Right to Care enter into an exclusive distribution and development collaboration (open source) agreement covering EQUIP in 17 developing countries to strengthen HIV (and other infectious disease) treatment and prevention. Johannesburg (South Africa), Boston…
Read more
Competitors and suppliers collaborate in the interests of advancing health technology

Jul 04, 2017

South Africa/Luxembourg, Tuesday, 4 July 2017: The Foundation for Professional Development (FPD) Group and Right to Care Group, joined forces to bring their healthcare technology under one umbrella for the advancement of health outcomes in developing countries. The new organisation which will house…
Read more
ABL Announces Distribution Agreement with Kron Científica e Industrial S.A. in Guatemala

Jun 27, 2017

Advanced Biological Laboratories (ABL) S.A. and Kron Científica e Industrial S.A. are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Guatemala. See current channel partners.
Read more